![James Caruso](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Caruso
Directeur Général chez
CELLECTAR BIOSCIENCES, INC.
Fortune : 32 354 $ au 30/06/2026
Profil
Mr. James V.
Caruso is a President, Chief Executive Officer & Director at Cellectar Biosciences, Inc. He is on the Board of Directors at Cellectar Biosciences, Inc. and Hip Innovation Technology LLC.
Mr. Caruso was previously employed as a Chief Commercial Officer & Executive VP by Allos Therapeutics, Inc., a Senior Vice President-Sales & Marketing by Bone Care International, Inc., a Vice President-Neuroscience Specialty Sales by Novartis Corp., a Vice President-Primary & Specialty Sales by BASF Pharma Ltd., and a Vice President-Sales by Knoll Pharmaceutical Co. He received his undergraduate degree from the University of Nevada.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 07/07/2026 | 11 638 ( 0,43 % ) | 32 354 $ | 30/06/2026 |
Postes actifs de James Caruso
| Sociétés | Poste | Début |
|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Directeur Général | 15/06/2015 |
Hip Innovation Technology LLC
 Hip Innovation Technology LLC Medical DistributorsDistribution Services Sells hip implant systems and components | Fondateur | 01/08/2010 |
Anciens postes connus de James Caruso
| Sociétés | Poste | Fin |
|---|---|---|
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Corporate Officer/Principal | 24/08/2010 |
Bone Care International, Inc.
 Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Developed innovative therapeutic and pharmaceutical products | Sales & Marketing | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Sales & Marketing | 01/06/2002 |
BASF Pharma Ltd.
 BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Produces excipients and active ingredients | Sales & Marketing | 01/05/2001 |
Knoll Pharmaceutical Co. | Sales & Marketing | 01/01/2001 |
Formation de James Caruso
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
43
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Bone Care International, Inc.
Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Developed innovative therapeutic and pharmaceutical products | Health Technology |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Hip Innovation Technology LLC
Hip Innovation Technology LLC Medical DistributorsDistribution Services Sells hip implant systems and components | Distribution Services |
BASF Pharma Ltd.
BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Produces excipients and active ingredients | Health Technology |
University of Nevada
 University of Nevada Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Knoll Pharmaceutical Co. | |
Cellectar Biosciences, Inc.
 Cellectar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer | Health Technology |
Choisissez Zonebourse 
